S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
UK train strikes and energy hikes add to a week of turmoil
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
UK train strikes and energy hikes add to a week of turmoil
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
UK train strikes and energy hikes add to a week of turmoil
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
UK train strikes and energy hikes add to a week of turmoil
NIH to fund unproven ALS drugs under patient-backed law
NASDAQ:NEOG

Neogen - NEOG Stock Forecast, Price & News

$13.97
-0.59 (-4.05%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$13.92
$14.68
50-Day Range
$13.97
$23.25
52-Week Range
$13.91
$47.80
Volume
4.66 million shs
Average Volume
8.73 million shs
Market Capitalization
$1.51 billion
P/E Ratio
41.09
Dividend Yield
N/A
Price Target
$20.00

Neogen MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
43.2% Upside
$20.00 Price Target
Short Interest
Healthy
19.42% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.44mentions of Neogen in the last 14 days
Based on 37 Articles This Week
Insider Trading
Acquiring Shares
$923,758 Bought Last Quarter
Proj. Earnings Growth
8.93%
From $0.56 to $0.61 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.58 out of 5 stars

Medical Sector

145th out of 1,093 stocks

Diagnostic Substances Industry

4th out of 17 stocks

NEOG stock logo

About Neogen (NASDAQ:NEOG) Stock

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

NEOG Stock News Headlines

126% Average Gains While Stocks Crash
Investors have lost $15 trillion so far, and it's about to get much worse. But Dr. Martin Weiss offers the solution with “Crash Profits Trades.” These could have produced average gains of 126% with NO losing trades, even with stocks tumbling! Click here to discover Crash Profit Trades. pixel
Neogen (NASDAQ:NEOG) Trading Up 1.7% on Insider Buying Activity
In 20 years, this little-known trader didn’t have a single losing year… 
In his debut video, Market Wizard Larry Benedict reveals how to make all the money you need, in any market, using a single stock.  Click here to watch the video and get the name and ticker of the one stock that could put you on the road to financial success. Click here to learn more. pixel
Recap: Neogen Q1 Earnings
Neogen 1Q Profit Drops After Booking Acquisition Costs
Neogen Corporation (NEOG) Q1 2023 Earnings Call Transcript
Neogen (NEOG) Q1 Earnings and Revenues Lag Estimates
Neogen Announces CFO Transition
Neogen Q1 2023 Earnings Preview - Seeking Alpha
Neogen (NEOG) Launches Test for Detection of Cashew Allergen
See More Headlines
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

NEOG Company Calendar

Last Earnings
7/26/2022
Today
10/02/2022
Next Earnings (Estimated)
12/20/2022
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
Employees
1,039
Year Founded
1982

Price Target and Rating

Average Stock Price Forecast
$20.00
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+43.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$48.31 million
Pretax Margin
8.50%

Debt

Sales & Book Value

Annual Sales
$527.16 million
Cash Flow
$0.82 per share
Book Value
$8.20 per share

Miscellaneous

Free Float
107,051,000
Market Cap
$1.51 billion
Optionable
Optionable
Beta
0.61

Social Links


Key Executives

  • Mr. John Edward Adent (Age 54)
    Pres, CEO & Director
    Comp: $844.43k
  • Mr. Steven J. QuinlanMr. Steven J. Quinlan (Age 60)
    VP & CFO
    Comp: $381.33k
  • Mr. Douglas E. Jones (Age 52)
    COO & VP
    Comp: $474.62k
  • Sarah Demey
    Admin. Mang.
  • Ms. Amy M. Rocklin Ph.D. (Age 50)
    VP, Gen. Counsel & Corp. Sec.
  • Ms. Julie A. Mann (Age 57)
    VP & Chief HR Officer













NEOG Stock - Frequently Asked Questions

Should I buy or sell Neogen stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" NEOG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEOG, but not buy additional shares or sell existing shares.
View NEOG analyst ratings
or view top-rated stocks.

What is Neogen's stock price forecast for 2022?

1 brokers have issued 1-year target prices for Neogen's stock. Their NEOG share price forecasts range from $20.00 to $20.00. On average, they predict the company's stock price to reach $20.00 in the next twelve months. This suggests a possible upside of 43.2% from the stock's current price.
View analysts price targets for NEOG
or view top-rated stocks among Wall Street analysts.

How have NEOG shares performed in 2022?

Neogen's stock was trading at $45.41 on January 1st, 2022. Since then, NEOG shares have decreased by 69.2% and is now trading at $13.97.
View the best growth stocks for 2022 here
.

When is Neogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 20th 2022.
View our NEOG earnings forecast
.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) issued its quarterly earnings results on Tuesday, July, 26th. The company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.02. The company had revenue of $140.09 million for the quarter, compared to analysts' expectations of $138.37 million. Neogen had a net margin of 6.86% and a trailing twelve-month return on equity of 7.60%.

When did Neogen's stock split?

Neogen's stock split on the morning of Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly minted shares were distributed to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com. John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

How do I buy shares of Neogen?

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $13.97.

How much money does Neogen make?

Neogen (NASDAQ:NEOG) has a market capitalization of $1.51 billion and generates $527.16 million in revenue each year. The company earns $48.31 million in net income (profit) each year or $0.34 on an earnings per share basis.

How many employees does Neogen have?

The company employs 1,039 workers across the globe.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The official website for the company is www.neogen.com. The company can be reached via phone at (517) 372-9200, via email at ir@neogen.com, or via fax at 517-372-2006.

This page (NASDAQ:NEOG) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.